Gilead Sciences Inc (GILD)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 690,000 | 6,859,000 | 5,814,000 | 8,278,000 | 1,669,000 |
| Revenue | US$ in thousands | 28,754,000 | 27,116,000 | 27,281,000 | 27,305,000 | 24,689,000 |
| Pretax margin | 2.40% | 25.30% | 21.31% | 30.32% | 6.76% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $690,000K ÷ $28,754,000K
= 2.40%
The pretax margin of Gilead Sciences Inc has exhibited fluctuations over the years as follows:
- As of December 31, 2020, the pretax margin was 6.76%, indicating that for every dollar of revenue, the company retained $0.0676 before taxes.
- By December 31, 2021, there was a significant improvement in the pretax margin to 30.32%, reflecting a substantial increase in profitability.
- However, the pretax margin decreased to 21.31% as of December 31, 2022, suggesting a drop in the company's profitability compared to the previous year.
- It rebounded to 25.30% by December 31, 2023, showing a recovery in profitability.
- The pretax margin dropped notably to 2.40% as of December 31, 2024, which is substantially lower compared to the previous years.
Overall, the pretax margin of Gilead Sciences Inc has shown variability, with periods of both improvement and decline in profitability over the years under review.
Peer comparison
Dec 31, 2024